|
|
Corporate
-
Alliances & Joint Ventures
Mylan, Natco tie up to market drug
Hyderabad, June 10
Natco Pharma Ltd tied up with Pittsburgh-based
Mylan Inc for worldwide marketing and
distribution of its glatiramer acetate pre-filled syringes
used to treat multiple sclerosis. Glatiramer acetate is a
generic version of Teva Pharmaceuticals' CopaxoneR.
According to a license and supply agreement signed by
the Hyderabad-based company and Mylan, the latter
acquired exclusive distribution rights for the drug in the
US and all major markets in Europe, Australia, New
Zealand, Japan and Canada including an option to
expand into additional markets. "We believe that no
company is better positioned than Mylan to help us
unlock the extraordinary value of this product in the US
and around the world," Mr V.C. Nannapaneni, Chairman
and Managing Director, Natco Pharma said in a release.
- Our Bureau
More Stories on :
Alliances & Joint Ventures |
Pharmaceuticals
Article
E-Mail
::
Comment
::
Syndication
::
Printer Friendly Page
|
Stories in this Section
Bosch Chassis considering hiking offer price for buyback
Tata Motors seeks to raise $1 b abroad
Award for Shanta Biotech chief
Business excellency award
MCF takes up rainwater harvesting
Grasim sells sponge iron unit to Welspun Power
Sun has to decide on Taro promoters’ stake this month
Anil Products to expand capacity, target Rs 50 cr exports in FY10
Mantri Developers to re-enter Pune with realty projects
Sanghi Polyesters to raise Rs 200 cr PE funds
Archean group picks up stake in Senegal phosphoric acid co
Omaxe forays into Dubai market
Aurobindo’s pill gets USFDA nod
Labour problem at Hindalco unit settled
Mylan, Natco tie up to market drug
IDFC picks up 22% in Seaways Shipping
Mando India looks to double turnover this year
Marriott plans to line up new properties
Hind Motors sees parts biz as growth driver
|
|
